Regulatory News
Thursday, August 25, 2016
BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification'
* Co and Eisai Inc have received a 'paragraph IV
certification' notification with respect to patents for Belviq
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment